Diary - News
All news Adocia receives Deloitte price
Adocia, a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins, especially insulins for diabetes treatment, announces that it received the “Listed Company” prize for the Grand Rhône-Alpes region during the 15th Deloitte In Extenso Technology Fast 50 event in Lyon.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree